Concepedia

Brian J. Long

BJ

46

Publications

4.4K

Citations

32

H-Index

1992

Active since

Affiliations

University of Maryland, Baltimore(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of North Carolina at Chapel Hill

U-M Rogel Cancer Center

The University of Texas MD Anderson Cancer Center

Brian J. Long is an author at University of Maryland, Baltimore specializing in medicine, pharmacology, and tumor biology.

Top concepts

MedicinePharmacologyTumor BiologyAromataseBreast CancerBiochemistryEndocrinologyDrug DiscoveryRadiation OncologyCell Biology

Publications per year

1992–2022

46

Publications

46

Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

Erick J. Morris, Sharda Jha, Clifford R. Restaino et al. · Cancer Discovery · 2013 · 673 citations · Full text

Pharmacotherapy, Tumor Biology, Drug Resistance +20

An orally available non-nucleotide STING agonist with antitumor activity

Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 609 citations

Antitumor Activity, Immunology, Immunoediting +19

Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression

Tikvah K. Hayes, Nicole F. Neel, Chaoxin Hu et al. · Cancer Cell · 2015 · 271 citations · Full text

Oncology, Pancreatic Cancer, Long-term Erk Inhibition +10

Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy

Amy D. Guertin, Jing Li, Yaping Liu et al. · Molecular Cancer Therapeutics · 2013 · 169 citations

Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens.

Apinya Thiantanawat, Brian J. Long, Angela Brodie · PubMed · 2003 · 162 citations

Aromatase Inhibitors, Breast Oncology, Oncology +15

Rows per page

1–5 of 46